Cabalse, Ken David Q.
HRN: 28-10-73 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
11/18/2025
11/25/2025
PO
9ML
BID
RHINOSINUSITIS
Checking Final Appropriateness